Literature DB >> 30538301

Combination therapy for advanced and metastatic kidney cancer.

Chung-Han Lee1, Robert J Motzer2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30538301     DOI： 10.1038/s41585-018-0133-7

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Comprehensive analysis of a new prognosis signature based on histone deacetylases in clear cell renal cell carcinoma.

Authors:  Fajuan Cheng; Bin Zheng; Jianwei Wang; Guiting Zhao; Zhongshun Yao; Zhihong Niu; Wei He
Journal:  Cancer Med       Date:  2021-07-26       Impact factor: 4.452
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.